Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile?

Personalised drug dosing through therapeutic drug monitoring (TDM) is important to maximise efficacy and to minimise toxicity. Hurdles preventing broad implementation of TDM in routine care include the need of sophisticated equipment and highly trained staff, high costs and lack of timely results. S...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinical pharmacokinetics Ročník 63; číslo 3; s. 269 - 278
Hlavní autoři: Davies Forsman, Lina, Kim, Hannah Yejin, Nguyen, Thi Anh, Alffenaar, Jan-Willem C.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Cham Springer International Publishing 01.03.2024
Springer Nature B.V
Témata:
ISSN:0312-5963, 1179-1926, 1179-1926
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Personalised drug dosing through therapeutic drug monitoring (TDM) is important to maximise efficacy and to minimise toxicity. Hurdles preventing broad implementation of TDM in routine care include the need of sophisticated equipment and highly trained staff, high costs and lack of timely results. Salivary TDM is a non-invasive, patient-friendly alternative to blood sampling, which has the potential to overcome barriers with traditional TDM. A mobile UV spectrophotometer may provide a simple solution for analysing drug concentrations in saliva samples. Salivary TDM utilising point-of-care tests can support personalised dosing in various settings including low-resource as well as remote settings. In this opinion paper, we describe how hurdles of implementing traditional TDM may be mitigated by salivary TDM with new strategies for patient-friendly point-of-care testing.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0312-5963
1179-1926
1179-1926
DOI:10.1007/s40262-024-01346-7